[Duration of disease and survival time in plasmacytoma].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000367:Age Factors; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001806:Blood Urea Nitrogen; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005859:Germany, East; D006801:Humans; D007239:Infections / Q000150:complications; D007970:Leukopenia / Q000150:complications; D008017:Life Expectancy; D008297:Male; D008875:Middle Aged; D010954:Plasmacytoma / Q000150:complications / Q000188:drug therapy / Q000401:mortality*; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012737:Sex Factors; D013921:Thrombocytopenia / Q000150:complications; D013997:Time Factors; D014228:Triaziquone / Q000627:therapeutic use; D014511:Uremia / Q000150:complications; D014527:Uric Acid / Q000097:blood
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D014527:Uric Acid; D003520:Cyclophosphamide; D014228:Triaziquone; D011241:Prednisone
Krankheitsdauer und Uberlebenszeit beim Plasmozytom.